Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly PTPN11 gene mutation. (Mutation of the protein tyrosine phosphatase, non-receptor type 11 gene. It is seen in cases of juvenile myelomonocytic leukemia.)
No clinical trials have been registered for acute myeloid leukemia, PTPN11 gene mutation.
4 publications have been identified in PubMed for acute myeloid leukemia, PTPN11 gene mutation. Research spans Epidemiology / Natural History (75%) and Case Report / Case Series (25%).
Nguyen VT (2025). [PMID: 41230857](https://pubmed.ncbi.nlm.nih.gov/41230857/). *Human pathology*. [Case Report / Case Series]
He L (2025). [PMID: 40663075](https://pubmed.ncbi.nlm.nih.gov/40663075/). *Clinical laboratory*. [Epidemiology / Natural History]
Sheng L (2024). [PMID: 39192399](https://pubmed.ncbi.nlm.nih.gov/39192399/). *Zhongguo shi yan xue ye xue za zhi*. [Epidemiology / Natural History]
Liu J (2024). [PMID: 39743269](https://pubmed.ncbi.nlm.nih.gov/39743269/). *Zhongguo shi yan xue ye xue za zhi*. [Epidemiology / Natural History]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:58 PM UTC
Common questions about acute myeloid leukemia, PTPN11 gene mutation